Within the past years, up to 78% of FDA-regulated clinical trials for the top pharmaceutical & medical device companies are conducted outside the U.S.
In the past 15 months, since the World Health Organization declared Covid-19 as a pandemic, healthcare systems around the globe have been under immense clinical trials R&D and regulatory pressure.
The United States has what is arguably the most complex healthcare system in the world. As a result, changes within the industry are slow. To understand what may come, it helps to have a deeper understanding of healthcare’s complexity.
The challenges from the impact of COVID-19 in the Clinical Research has pivot into decentralized (virtual) Clinical Research trials.
During the past year 2020 and present 2021 our company has engaged in diverse solutions to catalyzed or accelerate processes in diverse angles in this global pandemic, internally and externally, to our Life Sciences clients.
Dr. Jorge Estrella, President & CMO at ESTERN Medical CRO Life Sciences, was part of virtual round table at The Economist Antibodies Inc: America’s Healthcare Revolution Virtual Roundtable meeting.
This past week Dr. Jorge Estrella, President & Chief Medical Officer at ESTERN Medical CRO Life Sciences, presented as of the Key Opinion Leaders (KOLs)
Over the last several weeks, our global nations have faced one of the most challenging times in our history. There is one thing that has not changed: our company’s continued commitment to you and our Life Science Clients, Sponsors & Partners.
ESTERN Medical CRO with every detail thoroughly considered, from Start to Finish.
At ESTERN Medical, we use cookies to enhance your experience on our website and to ensure its proper functionality. By continuing to browse our site, you agree to our use of cookies.
For more information about how we use cookies and your rights, please see our Legal Policies.